INTC
Intel Corporation
INTC lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
MYSE
Myseum Inc.
There isn't enough reported data to score MYSE yet.
INTC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Healthy | |
| Healthy |
INTC's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.
MYSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Unavailable | |
| Unavailable |
MYSE's revenue is currently healthy, but its profitability is weak. There isn't enough data to rate its cash flow and balance sheet.
INTC PE Valuation
INTC has no meaningful PE right now: it lost money over the past year.
MYSE PE Valuation
MYSE has no meaningful PE right now: it lost money over the past year.
INTC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Broad | |
| Low |
Analysts expect earnings and revenue growth for INTC, with profitability improving. However, they disagree widely on these estimates.
MYSE Forward outlook
There aren't enough analyst estimates for MYSE to show an outlook.
INTC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.41 | — |
| Q3 2026 | -$2.39 | -24000% |
| Q2 2026 | -$2.09 | +$2.68 |
| Q1 2026 | -$0.60 | +$3.88 |
| Q4 2025 | -$0.06 | +$4.32 |
| Q3 2025 | $0.01 | +$3.72 |
| Q2 2025 | -$4.77 | -2088% |
| Q1 2025 | -$4.48 | -562% |
| Q4 2024 | -$4.38 | -1195% |
MYSE has the stronger earnings trend. Trailing diluted EPS is down 24,000% for INTC versus MYSE down 147%.
MYSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2021 | -$2.65 | -$1.88 |
| Q2 2021 | -$1.69 | -$0.94 |
| Q1 2021 | -$1.34 | +$1.66 |
| Q4 2020 | -$0.73 | +$4.51 |
MYSE lost $1.25 per share over the past year, a smaller loss than the year before.
INTC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16.5B | +21% |
| Q2 2026 | $16.1B | +25% |
| Q1 2026 | $13.6B | +7.2% |
| Q4 2025 | $13.7B | -4.1% |
| Q3 2025 | $13.7B | +2.8% |
| Q2 2025 | $12.9B | +0.2% |
| Q1 2025 | $12.7B | -0.4% |
| Q4 2024 | $14.3B | -7.4% |
INTC has the edge over MYSE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +10 points |
| Q2 2026 | 11% | +36 points |
| Q1 2026 | -23% | -21 points |
| Q4 2025 | 4.2% | +1.4 points |
| Q3 2025 | 5% | +73 points |
| Q2 2025 | -25% | -9.4 points |
| Q1 2025 | -2.4% | +6 points |
| Q4 2024 | 2.9% | -14 points |
INTC has the edge over MYSE on profitability, with a higher operating margin.
MYSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $37 | -53% |
| Q1 2026 | $73 | -12% |
| Q4 2025 | $61 | -34% |
| Q3 2025 | $328 | +429% |
| Q2 2025 | $78 | -48% |
| Q1 2025 | $83 | -37% |
| Q4 2024 | $92 | -46% |
| Q3 2024 | $62 | -65% |
MYSE's revenue is growing: $37 last quarter, down 53% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -5817057% | -4013431 points |
| Q1 2026 | -2308863% | -308326 points |
| Q4 2025 | -1872431% | -663521 points |
| Q3 2025 | -390427% | +1606644 points |
| Q2 2025 | -1803626% | -964485 points |
| Q1 2025 | -2000537% | -730752 points |
| Q4 2024 | -1208910% | -373353 points |
| Q3 2024 | -1997071% | -544413 points |
MYSE's operating margin was −5817057% last quarter, down 4013431 points from the same quarter a year ago, near the bottom of its range since 2022.
INTC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +774% |
| Q2 2026 | $4.5B | +$6B |
| Q1 2026 | -$2.5B | +$1.8B |
| Q4 2025 | $800M | +$3.5B |
| Q3 2025 | $121M | +$2.5B |
| Q2 2025 | -$1.5B | +$1.9B |
| Q1 2025 | -$4.4B | +$2.8B |
| Q4 2024 | -$2.7B | -$597M |
INTC's free cash flow has turned positive after four years mostly in the red: $3.8B over the past year.
MYSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$1.3M | +$154.3K |
| Q1 2025 | -$1.4M | +$71.9K |
| Q4 2023 | -$1.4M | +$161.4K |
| Q3 2023 | -$2M | +$55.6K |
| Q3 2022 | -$2.1M | -$704.1K |
| Q1 2022 | -$2.3M | -$1.6M |
| Q3 2021 | -$1.3M | -$1M |
| Q1 2021 | -$650.2K | -$379.7K |
MYSE has burned cash in almost every quarter: −$4M over the past year, against −$6M the year before.
INTC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4% | +203M shares |
| 1 year | +17% | +776M shares |
| 3 years | +25% | +1.1B shares |
| 5 years | +30% | +1.2B shares |
| Available history | +19% | +834M shares |
INTC has the edge over MYSE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | $114M |
| Q1 2021 | $2.3B |
MYSE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +16% | +699K shares |
| 1 year | +18% | +771K shares |
| 3 years | +142% | +2.9M shares |
| 5 years | +272% | +3.6M shares |
MYSE has 5M diluted shares, up 18% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
| Q3 2019 | — |
INTC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.0x | Healthy |
| Q2 2026 | 3.1x | Elevated |
| Q1 2026 | 3.9x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 4.0x | Elevated |
| Q1 2025 | 69.6x | High |
| Q3 2024 | 23.8x | High |
| Q2 2024 | 4.3x | High |
INTC's net debt is about 2.0 years of its operating earnings (EBITDA), down from 4.0 years a year ago.
MYSE Net Leverage
MYSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
INTC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.1 | Neutral |
| Stochastic | 7.7 | Oversold |
INTC's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
MYSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.4 | Neutral |
| Stochastic | 0.6 | Oversold |
MYSE's weekly RSI is 34 (neutral) and its Stochastic is 1 (oversold).
INTC PE vs Technology Sector
| Metric | INTC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
INTC has no meaningful PE right now: it lost money over the past year.
MYSE PE vs Technology Sector
MYSE has no meaningful PE right now: it lost money over the past year.
INTC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $88.4 | 31% below |
| 20 week MA | $95.3 | 36% below |
| 50 week MA | $79.3 | 23% below |
| 100 week MA | $52.1 | 18% above |
| 200 week MA | $42.5 | 44% above |
INTC has the edge over MYSE on trend strength, trading above more of its moving averages.
MYSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.49 | 29% below |
| 20 week MA | $2.11 | 50% below |
| 50 week MA | $2.05 | 48% below |
| 100 week MA | $2.31 | 54% below |
| 200 week MA | $2.59 | 59% below |
MYSE is in a downtrend: it's below all five of its weekly moving averages, and 59% below its 200-week average.
INTC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $60.1 | $47.1 | -22% |
| 2021 | $47.1 | $51.3 | +9% |
| 2022 | $51.3 | $26.1 | -49% |
| 2023 | $26.1 | $50.3 | +93% |
| 2024 | $50.3 | $20.3 | -60% |
| 2025 | $20.3 | $36.2 | +78% |
| 2026 YTD | $36.2 | $61.2 | +69% |
INTC has the edge over MYSE on returns for 2026, with the stronger performance.
MYSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $34.2 | $33.9 | -0.9% |
| 2022 | $33.9 | $3.15 | -91% |
| 2023 | $3.15 | $2.87 | -8.9% |
| 2024 | $2.87 | $1.84 | -36% |
| 2025 | $1.84 | $1.87 | +1.6% |
| 2026 YTD | $1.87 | $1.06 | -43% |
MYSE has finished lower in four of the last five years. It's down 43% so far in 2026.